Eastman Chemical Company (BIT:1EMN)
Italy · Delayed Price · Currency is EUR 70.48
0.00 (0.00%)
At close: Aug 12, 2025, 5:30 PM CET
ROIC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 9,286 | 9,382 | 9,210 | 10,580 | 10,476 | 8,473 | |
Revenue Growth (YoY) | 1.52% | 1.87% | -12.95% | 0.99% | 23.64% | -8.63% |
Cost of Revenue | 7,047 | 7,085 | 7,134 | 8,443 | 7,972 | 6,490 |
Gross Profit | 2,239 | 2,297 | 2,076 | 2,137 | 2,504 | 1,983 |
Selling, General & Admin | 638 | 664 | 768 | 625 | 383 | 773 |
Research & Development | 265 | 250 | 239 | 264 | 254 | 226 |
Operating Expenses | 903 | 914 | 1,007 | 889 | 637 | 999 |
Operating Income | 1,336 | 1,383 | 1,069 | 1,248 | 1,867 | 984 |
Interest Expense | -218 | -216 | -225 | -182 | -198 | -210 |
Interest & Investment Income | 15 | 16 | 10 | - | - | - |
Earnings From Equity Investments | -2 | - | 10 | 19 | 16 | 15 |
Currency Exchange Gain (Loss) | -6 | -11 | -11 | -16 | -10 | -16 |
Other Non Operating Income (Expenses) | -57 | -36 | -37 | -3 | 11 | -7 |
EBT Excluding Unusual Items | 1,068 | 1,136 | 816 | 1,066 | 1,686 | 766 |
Merger & Restructuring Charges | -69 | -58 | -60 | -52 | -48 | -110 |
Gain (Loss) on Sale of Assets | - | - | 323 | -43 | -552 | - |
Asset Writedown | - | - | - | - | -3 | -125 |
Other Unusual Items | - | - | - | 6 | -1 | -1 |
Pretax Income | 999 | 1,078 | 1,087 | 977 | 1,082 | 530 |
Income Tax Expense | 164 | 170 | 191 | 181 | 215 | 41 |
Earnings From Continuing Operations | 835 | 908 | 896 | 796 | 867 | 489 |
Net Income to Company | 835 | 908 | 896 | 796 | 867 | 489 |
Minority Interest in Earnings | -3 | -3 | -2 | -3 | -10 | -11 |
Net Income | 832 | 905 | 894 | 793 | 857 | 478 |
Net Income to Common | 832 | 905 | 894 | 793 | 857 | 478 |
Net Income Growth | -5.78% | 1.23% | 12.74% | -7.47% | 79.29% | -37.02% |
Shares Outstanding (Basic) | 116 | 117 | 119 | 124 | 135 | 136 |
Shares Outstanding (Diluted) | 117 | 118 | 119 | 125 | 137 | 137 |
Shares Change (YoY) | -1.68% | -1.26% | -4.40% | -8.90% | 0.44% | -1.44% |
EPS (Basic) | 7.20 | 7.75 | 7.54 | 6.42 | 6.35 | 3.53 |
EPS (Diluted) | 7.12 | 7.67 | 7.49 | 6.35 | 6.25 | 3.50 |
EPS Growth | -4.20% | 2.40% | 17.95% | 1.60% | 78.57% | -36.13% |
Free Cash Flow | 406 | 688 | 546 | 364 | 1,064 | 1,072 |
Free Cash Flow Per Share | 3.48 | 5.83 | 4.57 | 2.91 | 7.76 | 7.85 |
Dividend Per Share | 3.300 | 3.260 | 3.180 | 3.070 | 2.830 | 2.670 |
Dividend Growth | 2.48% | 2.52% | 3.58% | 8.48% | 5.99% | 5.95% |
Gross Margin | 24.11% | 24.48% | 22.54% | 20.20% | 23.90% | 23.40% |
Operating Margin | 14.39% | 14.74% | 11.61% | 11.80% | 17.82% | 11.61% |
Profit Margin | 8.96% | 9.65% | 9.71% | 7.50% | 8.18% | 5.64% |
Free Cash Flow Margin | 4.37% | 7.33% | 5.93% | 3.44% | 10.16% | 12.65% |
EBITDA | 1,845 | 1,892 | 1,544 | 1,725 | 2,405 | 1,558 |
EBITDA Margin | 19.87% | 20.17% | 16.76% | 16.30% | 22.96% | 18.39% |
D&A For EBITDA | 509 | 509 | 475 | 477 | 538 | 574 |
EBIT | 1,336 | 1,383 | 1,069 | 1,248 | 1,867 | 984 |
EBIT Margin | 14.39% | 14.74% | 11.61% | 11.80% | 17.82% | 11.61% |
Effective Tax Rate | 16.42% | 15.77% | 17.57% | 18.53% | 19.87% | 7.74% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.